Spontaneous and genetically engineered animal models: use in preclinical cancer drug development

被引：156

作者：

Hansen, K ^{[1
]}

Khanna, C ^{[1
]}

机构：

[1] NCI, Canc Res Ctr, Comparat Oncol Program, NIH, Rockville, MD USA

来源：

EUROPEAN JOURNAL OF CANCER | 2004年 / 40卷 / 06期

关键词：

cancers; GEM; mouse; transgenic; canine comparative; spontaneous;

D O I：

10.1016/j.ejca.2003.11.031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The preclinical development of anticancer drugs has been based primarily on the transplantation of murine or human cancers into mice. Alternatives to these transplantation models are animals that naturally develop cancers with features relevant to the human disease. The first group of these models arises in mice that are genetically engineered to develop cancer. The second group includes pet dogs and cats that naturally develop cancer. This review will discuss the use and integration of these spontaneous cancer models into a comprehensive and comparative approach to preclinical drug development. Examples of their successful use and an outline of their relative strengths and weaknesses will be provided. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：858 / 880

页数：23

共 152 条

[1]

Ahern TE, 1996, AM J VET RES, V57, P693

[2] Prospective identification of tumorigenic breast cancer cells [J].

Al-Hajj, M ;

Wicha, MS ;

Benito-Hernandez, A ;

Morrison, SJ ;

Clarke, MF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988

[3] Use of transgenic mice in identifying chemopreventive agents [J].

Alexander, J .

TOXICOLOGY LETTERS, 2000, 112 :507-512

[4]

Anderson PM, 1999, CLIN CANCER RES, V5, P2316

[5] Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-γ delivery is associated with macrophages recruitment and nitric oxide production [J].

Baratin, M ;

Ziol, M ;

Romieu, R ;

Kayibanda, M ;

Gouilleux, F ;

Briand, P ;

Leroy, P ;

Haddada, H ;

Rénia, L ;

Viguier, M ;

Guillet, JG .

CANCER GENE THERAPY, 2001, 8 (03) :193-202

[6] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].

Bergers, G ;

Brekken, R ;

McMahon, G ;

Vu, TH ;

Itoh, T ;

Tamaki, K ;

Tanzawa, K ;

Thorpe, P ;

Itohara, S ;

Werb, Z ;

Hanahan, D .

NATURE CELL BIOLOGY, 2000, 2 (10) :737-744

[7] Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].

Bergers, G ;

Javaherian, K ;

Lo, KM ;

Folkman, J ;

Hanahan, D .

SCIENCE, 1999, 284 (5415) :808-812

[8]

Bergman PJ, 2003, CLIN CANCER RES, V9, P1284

[9] Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993) [J].

Bergman, PJ ;

MacEwen, EG ;

Kurzman, ID ;

Henry, CJ ;

Hammer, AS ;

Knapp, DW ;

Hale, A ;

Kruth, SA ;

Klein, MK ;

Klausner, J ;

Norris, AM ;

McCaw, D ;

Straw, RC ;

Withrow, SJ .

JOURNAL OF VETERINARY INTERNAL MEDICINE, 1996, 10 (02) :76-81

[10] Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-Lox recombination [J].

Bex, A ;

Vooijs, M ;

Horenblas, S ;

Berns, A .

JOURNAL OF UROLOGY, 2002, 168 (06) :2641-2644

← 1 2 3 4 5 6 7 8 9 10 →